Cure
- Company typePrivate
- Founded2020
- HeadquartersNew York, United States
- Headcount51–100
- GTM typeB2B
- OfferingServices
Cure firmographics
Firmographics- Name
- Cure
- Legal name
- Cure Experience Services LLC
- Website
- https://wewillcure.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Ownership category
- akta.pro rank
Where Cure is headquartered
LocationHeadquarters
- HQ city
- New York
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Cure business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Infrastructure, Personnel, Operations, Marketing or Sales, Technology or R&D
Revenue model
- Membership Programs: Cure generates revenue through tiered membership programs (Digital+, Premium, Platinum, Enterprise) providing access to workspace, events, expert guidance, investor connections, and community platform.
- Event Space Rental: Cure rents its premium event venues including Rooftop Terrace (up to 180 people), Education and Conference Center (up to 460 people), and Executive Center (up to 140 people) for healthcare and biotech events.
- Collaboration Residency: State-of-the-art office and workspace environment for healthcare leaders offering fully outfitted footprints, with resident companies including startups and established enterprises.
- Sponsorships: Corporate sponsorships for events and programs, providing brand visibility, thought leadership opportunities, and access to Cure's ecosystem of innovators and investors.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Digital+ Membership |
| Subscription | Annual | Premium Membership |
| Subscription | Annual | Platinum Membership |
| Subscription | Annual | Enterprise Membership |
Go-to-market motion3 records
Distribution channels5 records
Marketing channels7 records
Cure product offering
Product offeringCore offering
Cure operates a New York City healthcare innovation campus at 345 Park Avenue South, providing a connected ecosystem of services for biomedical innovators. It sells tiered memberships (Digital+, Premium, Platinum, Enterprise), collaboration residency offices and wet/dry lab space, three event venues, the proprietary Cure Innovation Index data platform that ranks 303 U.S. biomedical research institutions, accelerator programs, and original benchmark reports and white papers.
Product overview
Cure is a healthcare innovation ecosystem headquartered in New York City operating multiple interconnected offerings: the Cure Innovation Index (a data-driven benchmarking platform ranking 303+ U.S. biomedical institutions across Research Capabilities, Entrepreneurial Readiness, and Market Translation using 25 indicators); Cure Membership (Digital+, Premium, Platinum, Enterprise tiers providing community access, masterclasses, expert meetings, reports, and workspace); Collaboration Residency (wet/dry labs and office spaces at 345 Park Avenue South); Event Spaces (Rooftop Terrace, Education and Conference Center, Executive Center for hosting healthcare events); Cure Original Reports and White Papers (benchmark reports and sector analyses); XSeed Award (funding for minority/women-led drug development startups); and the Cure by Deerfield Middle East Health Accelerator (12-week hybrid program for 15 startup cohorts with mentorship and pilot opportunities). The ecosystem also hosts flagship events including the X Factor Healthcare Innovation Summit and Power of X: Women's Health Innovation Summit.
Differentiator
Problem solved
Functional benefit
Brands
- Cure Innovation Index: First evidence-based ranking of U.S. biomedical research institutions measuring translational performance.
- Cure by Deerfield Middle East Health Accelerator
- XSeed Award
Products and services
- Cure Innovation Index Evidence-based national ranking and benchmarking platform measuring translational performance of 303 U.S. biomedical research institutions across Research Capabilities, Entrepreneurial Readiness, and Market Translation using 25 indicators, surveys of 3,300+ researchers, and federal and commercial data sources.
- Cure Membership
Quantifiable outcome
- 3 out of 4 researchers unable to fund proof-of-concept work (systemic barrier Cure addresses)
- +3 more outcomes
Companies that use Cure
Customer profileNamed customers7 records
Segments4 records
Ideal customer profiles4 records
Cure technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Cure partnerships and signals
Strategic signalPartnerships
15 partnerships are on record, tiered flagship and core.
- Women's Health HorizonsflagshipPower of X Summit focused on women's health innovation, bringing together over 300 investors, clinicians, and entrepreneurs to make the case for women's health as an investable market.
- Biotechnology InstitutecoreCure partnered with the Biotechnology Institute to support the BioGENEius Challenge, hosting the flagship program during BioFuture Conference in October 2024 to engage and educate students about biotechnology.
- EvvycoreCure partnered with Evvy to host leaders across healthcare, policy, tech and media addressing the gender health gap and highlighting Equal Research Day.
- United Nations (SSUNGA)flagshipCure hosts the Science Summit UN General Assembly (SSUNGA) bringing together thought leaders, scientists, innovators, policymakers and financiers to increase collaborations for UN Sustainable Development Goals.
- Scientific AmericanflagshipCure and Scientific American co-host the FutureHealth event series covering Breakthroughs, Holistic Health and Wellness, and Reimagining Healthcare topics to showcase healthcare innovation stories and their global impact.
- Clinton Global InitiativeflagshipCure partnered with Clinton Global Initiative to address global health equity, AI, climate, and maternal health issues through collaborative innovations across disciplines and geographies.
- Life Science Cares New YorkcoreScience Day program launched in partnership with Life Science Cares New York and Science In the City Inc., bringing 50 NYC high school students to Cure campus for life sciences education.
- New York Academy of SciencescoreCure and NY Academy of Sciences partnered on programs exploring how startups leverage AI for drug discovery and development, gathering industry and academic experts.
- New York City Economic Development CorporationcoreNYC EDC sponsored Science Day program, supporting the initiative to bring life sciences education to NYC high school students at Cure campus.
- Women's Health HorizonsflagshipCo-hosted Power of X Summit March 2025, bringing together leaders from science, medicine, investment, and policy to foster women's health innovation with CIF Catalytic Innovation Prize.
- Federal DatabasescoreCure Innovation Index sources data from federal databases to rank 303 biomedical research institutions across three domains.
- Commercial Data ProviderscoreCure Innovation Index uses commercial data providers alongside federal databases for its 25-indicator methodology.
- CirclecoreCircle provides the community platform for Cure Membership (community.wewillcure.com) with their own privacy practices.
- StripecoreStripe handles payment processing for Cure Membership Community as third-party payment processor.
- HubSpotcoreHubSpot sets cookies for tracking visitors and maintaining session consistency for user experience optimization.
Scale indicators10 records
Recent moves7 records
Expansion highlights5 records
Cure competitors and assessment
Company assessmentDirect peers
- Alexandria LaunchLabs: Alexandria Real Estate's life science incubator and coworking platform operates turnkey lab and office space at multiple locations. It is the closest direct competitor to Cure's collaboration residency model and is significantly larger and more geographically distributed.
- LabCentral: Nonprofit life science innovation hub in Cambridge, MA providing coworking lab space, events, and community for biotech startups. Directly comparable to Cure's residency and community offerings, though Cure combines this with a benchmarking data product.
- BioGenerator: St. Louis-based nonprofit biotech and medtech incubator providing lab space, founder support, and venture funding. Comparable to Cure's accelerator and residency programs with a regional rather than NYC-centric footprint.
- Biolabs: Operator of shared lab and coworking spaces for life science startups across multiple U.S. and European cities. Closely comparable to Cure's collaboration residency and membership model with broader geographic reach.
- IndieBio: SOSV-operated biotech accelerator providing lab space, mentorship, and seed capital to early-stage life science startups globally. Comparable to Cure's accelerator and XSeed programs but with a venture-fund model rather than Deerfield-backed capital.
Broad incumbents
- JLABS (Johnson & Johnson Innovation): Johnson & Johnson's global network of life science incubators offering lab space, mentorship, and venture support across multiple cities. Operates as a strategic corporate platform rather than an independent ecosystem, and has materially greater capital and global reach than Cure.
Regional players
- MaRS Discovery District: Toronto-based innovation hub offering coworking, accelerator programs, and community for health, cleantech, and fintech startups. Comparable ecosystem model to Cure but serving a Canadian rather than NYC market.
- University City Science Center: Philadelphia-based research park and innovation hub supporting life science and tech startups with lab space, programming, and venture support. Comparable to Cure's campus-driven model but serving a different regional cluster.
Emerging players
- Cambridge Innovation Center (CIC): Global operator of large-scale innovation and coworking campuses with a health-focused vertical. Comparable to Cure's membership and event model but broader in scope, with deeper venture-tenant infrastructure.
- Plug and Play Health: Corporate-backed health innovation platform connecting startups with enterprise healthcare partners through accelerator cohorts. Comparable to Cure's accelerator and corporate sponsorship model, with a focus on enterprise- startup matchmaking rather than physical residency.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Cure social profiles
Digital presenceCure financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cure leadership team
Management profileNumber of profiles
Profiles8 records
Cure funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cure M&A and investment
M&A and investmentM&A
Investments2 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cure
What does Cure do?
Cure operates a New York City healthcare innovation campus at 345 Park Avenue South, providing a connected ecosystem of services for biomedical innovators. It sells tiered memberships (Digital+, Premium, Platinum, Enterprise), collaboration residency offices and wet/dry lab space, three event venues, the proprietary Cure Innovation Index data platform that ranks 303 U.S. biomedical research institutions, accelerator programs, and original benchmark reports and white papers.
Is Cure a public or private company?
Cure is a private company. It is classified as venture growth investor backed and is currently operating.
When was Cure founded?
Cure was founded in 2020. It employs 51 to 100 people.
Where is Cure based?
Cure is headquartered in New York, United States, in the North America region.
How does Cure make money?
Four revenue lines are on record. Membership Programs are the primary driver. The others are event Space Rental, collaboration Residency and sponsorships.
Who are Cure's main competitors?
Direct peers on record are Alexandria LaunchLabs, LabCentral, BioGenerator, Biolabs and IndieBio. JLABS (Johnson & Johnson Innovation) is listed as a broad incumbent. Regional players are MaRS Discovery District and University City Science Center. Emerging players are Cambridge Innovation Center (CIC) and Plug and Play Health.
Does Cure have an API?
No public API is recorded for Cure.